• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年及儿童肾细胞癌的特征:来自儿童肿瘤研究组AREN03B2研究的报告

Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

作者信息

Geller James I, Ehrlich Peter F, Cost Nicholas G, Khanna Geetika, Mullen Elizabeth A, Gratias Eric J, Naranjo Arlene, Dome Jeffrey S, Perlman Elizabeth J

机构信息

Division of Pediatric Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.

Section of Pediatric Surgery, Department of Surgery, CS Mott Children's Hospital, University of Michigan School of Medicine, Ann Arbor, Michigan.

出版信息

Cancer. 2015 Jul 15;121(14):2457-64. doi: 10.1002/cncr.29368. Epub 2015 Apr 6.

DOI:10.1002/cncr.29368
PMID:25845370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4588054/
Abstract

BACKGROUND

The current study was conducted to characterize the epidemiology, histology, and radiographic features of as well as the surgical approach to pediatric and adolescent renal cell carcinoma (pRCC).

METHODS

pRCC cases prospectively enrolled on the Children's Oncology Group study AREN03B2 underwent central pathology, radiology, surgery, and oncology review.

RESULTS

As of June 2012, 120 of a total of 3250 patients enrolled on AREN03B2 (3.7%) were found to have unilateral RCC (median age, 12.9 years [range, 1.9-22.1 years]; 52.5% were female). Central review classified these as translocation morphology (56 patients), papillary (20 patients), renal medullary carcinoma (13 patients), chromophobe (4 patients), oncocytoma (1 patient), conventional clear cell (1 patient), and RCC not otherwise specified (25 patients). Lymph node (LN) involvement (N+) was found in 35 of 73 cases (47.9%) for which LNs were sampled, including 19 of 40 cases with primary tumors measuring <7 cm (47.5%). Using a size cutoff of 1 cm, imaging detection of LN involvement had a sensitivity of 57.14% (20 of 35 cases; 95% CI, 39.35%-73.68%) and a specificity of 94.59% (35 of 37 cases; 95% CI, 81.81%-99.34%). Distant metastases were present in 23 cases (19.2%). Initial surgery was radical nephrectomy in 88 patients (73.3%), nephron-sparing surgery in 18 patients (15.0%), and biopsy in 14 patients (11.7%). Compared with patients undergoing radical nephrectomy, those treated with nephron-sparing surgery were less likely to have LNs sampled (6 of 18 patients [33.3%] vs 65 of 88 patients [73.9%]; P = .002).

CONCLUSIONS

Translocation RCC is the most common form of pediatric and adolescent RCC. Lymph node disease is common and observed among patients with small primary tumors. Imaging has a high specificity but relatively low sensitivity for the detection of such lymph node disease. Failure to sample LNs results in incomplete staging and potentially inadequate disease control for younger patients with RCC.

摘要

背景

本研究旨在描述儿童及青少年肾细胞癌(pRCC)的流行病学、组织学、影像学特征以及手术方式。

方法

对前瞻性纳入儿童肿瘤协作组AREN03B2研究的pRCC病例进行中心病理学、放射学、手术及肿瘤学评估。

结果

截至2012年6月,在AREN03B2研究纳入的3250例患者中,有120例(3.7%)被发现患有单侧肾细胞癌(中位年龄12.9岁[范围1.9 - 22.1岁];52.5%为女性)。中心评估将这些病例分类为易位型(56例)、乳头状(20例)、肾髓质癌(13例)、嫌色细胞型(4例)、嗜酸细胞瘤(1例)、传统透明细胞型(1例)以及未另行指定的肾细胞癌(25例)。在73例进行了淋巴结采样的病例中,有35例(47.9%)发现有淋巴结转移(N+),其中在40例原发肿瘤直径<7 cm的病例中有19例(47.5%)。以1 cm为大小截断值,影像学检测淋巴结转移的敏感性为57.14%(35例中的20例;95%可信区间,39.35% - 73.68%),特异性为94.59%(37例中的35例;95%可信区间,81.81% - 99.34%)。远处转移见于23例(19.2%)。初始手术为根治性肾切除术的有88例(73.3%),保留肾单位手术的有18例(15.0%),活检的有14例(11.7%)。与接受根治性肾切除术的患者相比,接受保留肾单位手术的患者进行淋巴结采样的可能性较小(18例中的6例[33.3%]对88例中的65例[73.9%];P = 0.002)。

结论

易位型肾细胞癌是儿童及青少年肾细胞癌最常见的形式。淋巴结疾病常见,且在原发肿瘤较小的患者中也可观察到。影像学检测此类淋巴结疾病具有较高的特异性,但敏感性相对较低。未对淋巴结进行采样会导致分期不完整,并可能使年轻肾细胞癌患者的疾病控制不足。

相似文献

1
Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.青少年及儿童肾细胞癌的特征:来自儿童肿瘤研究组AREN03B2研究的报告
Cancer. 2015 Jul 15;121(14):2457-64. doi: 10.1002/cncr.29368. Epub 2015 Apr 6.
2
Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.儿童、青少年和青年单侧非转移性肾细胞癌患者手术时淋巴结采样的相关因素。
J Pediatr Urol. 2019 May;15(3):259.e1-259.e7. doi: 10.1016/j.jpurol.2019.01.009. Epub 2019 Feb 1.
3
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.一项儿童和青少年肾细胞癌的前瞻性研究:来自儿童肿瘤学组 AREN0321 研究的报告。
Cancer. 2020 Dec 1;126(23):5156-5164. doi: 10.1002/cncr.33173. Epub 2020 Sep 14.
4
Radical Nephrectomy for Renal Cell Carcinoma:  Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study.肾细胞癌根治性肾切除术:其与组织学类型、肿瘤大小及淋巴结状态相关的当代作用:一项回顾性研究
Am J Clin Pathol. 2016 Jun;145(6):837-42. doi: 10.1093/ajcp/aqw059. Epub 2016 Apr 22.
5
Reassessment of the 1997 TNM classification system for renal cell carcinoma.对1997年肾细胞癌TNM分类系统的重新评估。
Cancer. 2003 Dec 1;98(11):2329-34. doi: 10.1002/cncr.11806.
6
Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.儿童和青年肾髓质癌的影像学表现:来自儿童肿瘤协作组的报告。
Pediatr Radiol. 2017 Nov;47(12):1615-1621. doi: 10.1007/s00247-017-3926-6. Epub 2017 Jul 8.
7
Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.I型和II型乳头状肾细胞癌(RCC)与透明细胞肾细胞癌的比较。
BJU Int. 2008 Nov;102(10):1381-4. doi: 10.1111/j.1464-410X.2008.07999.x. Epub 2008 Sep 8.
8
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.在多变量环境中,pNx/pN0分组对透明细胞肾细胞癌患者预后建模的影响。
J Urol. 2002 Jul;168(1):56-60.
9
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.组织学分型可预测非转移性肾细胞癌患者肾切除术后淋巴结侵犯的发生率。
Urol Oncol. 2020 May;38(5):537-544. doi: 10.1016/j.urolonc.2020.01.013. Epub 2020 Feb 29.
10
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.经聚焦遗传学检测后,在儿童肿瘤学组(COG)方案 AREN03B2 上登记的小儿和青年肾细胞癌的分类。
Cancer. 2018 Aug;124(16):3381-3389. doi: 10.1002/cncr.31578. Epub 2018 Jun 15.

引用本文的文献

1
Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinoma.表型筛选聚焦于CDK9抑制作为易位性肾细胞癌的一种治疗策略。
bioRxiv. 2025 Aug 30:2025.08.25.672235. doi: 10.1101/2025.08.25.672235.
2
Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategies.非透明细胞肾细胞癌的最新进展:生物学与治疗策略
Ther Adv Med Oncol. 2025 Jun 16;17:17588359251345722. doi: 10.1177/17588359251345722. eCollection 2025.
3
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinoma.TFE3融合癌蛋白凝聚物驱动易位性肾细胞癌中的转录重编程和癌症进展。
Cell Rep. 2025 Apr 22;44(4):115539. doi: 10.1016/j.celrep.2025.115539. Epub 2025 Apr 11.
4
A case of hypoglossal nerve palsy with evolving cranial nerve involvement in renal cell carcinoma: a case report.1例肾细胞癌伴舌下神经麻痹及逐渐发展的颅神经受累病例报告
J Med Case Rep. 2025 Apr 1;19(1):146. doi: 10.1186/s13256-025-05193-3.
5
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma.TFE3融合蛋白驱动易位性肾细胞癌中的氧化代谢和铁死亡抗性。
EMBO Mol Med. 2025 May;17(5):1041-1070. doi: 10.1038/s44321-025-00221-7. Epub 2025 Mar 27.
6
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.儿童非肾母细胞瘤性肾癌生物学的标志性发现。
Nat Rev Urol. 2025 Jan 29. doi: 10.1038/s41585-024-00993-6.
7
Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas.基于免疫及新型疗法在变异型组织学肾细胞癌中的应用
Cancers (Basel). 2025 Jan 20;17(2):326. doi: 10.3390/cancers17020326.
8
Pediatric Renal Cell Carcinoma (pRCC) Subpopulation Environmental Differentials in Survival Disadvantage of Black/African American Children in the United States: Large-Cohort Evidence.美国黑人和非裔美国儿童在小儿肾细胞癌(pRCC)亚群中的生存劣势与环境差异:大队列证据
Cancers (Basel). 2024 Nov 27;16(23):3975. doi: 10.3390/cancers16233975.
9
Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case report.转移性TFE3(小眼畸形转录因子)易位性肾细胞癌的治疗:一例报告
Transl Pediatr. 2024 Mar 27;13(3):499-507. doi: 10.21037/tp-24-35. Epub 2024 Mar 22.
10
Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study.使用机器学习预测肾细胞癌患者的淋巴结转移:一项基于人群的研究。
Front Public Health. 2023 Mar 24;11:1104931. doi: 10.3389/fpubh.2023.1104931. eCollection 2023.

本文引用的文献

1
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee.初次肾切除术和术中肿瘤溢出:来自儿童肿瘤学组(COG)肾脏肿瘤委员会的报告。
J Pediatr Surg. 2013 Jan;48(1):34-8. doi: 10.1016/j.jpedsurg.2012.10.015.
2
[Xp11.2 translocation renal carcinoma in adults over 50 years of age: about four cases].50岁以上成人Xp11.2易位性肾癌:附4例报告
Prog Urol. 2012 Nov;22(15):932-7. doi: 10.1016/j.purol.2012.06.009. Epub 2012 Jul 26.
3
A robotic-assisted laparoscopic approach for pediatric renal cell carcinoma allows for both nephron-sparing surgery and extended lymph node dissection.机器人辅助腹腔镜手术治疗小儿肾细胞癌,既能保留肾单位,又能进行淋巴结清扫术。
J Pediatr Surg. 2012 Oct;47(10):1946-50. doi: 10.1016/j.jpedsurg.2012.08.017.
4
Persistent complete response after single-agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma.一例TFE易位阳性复发性转移性小儿肾细胞癌经单药舒尼替尼治疗后持续完全缓解
J Pediatr Hematol Oncol. 2013 Jan;35(1):e1-3. doi: 10.1097/MPH.0b013e318266bf34.
5
Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.与转录因子 E3 表达和 Xp11.2 易位相关的肾细胞癌:发生率、特征和预后。
Am J Clin Pathol. 2012 May;137(5):761-8. doi: 10.1309/AJCPQ6LLFMC4OXGC.
6
Translocation renal cell carcinomas in adults: a single-institution experience.成人易位性肾细胞癌:单机构经验。
Am J Surg Pathol. 2012 May;36(5):654-62. doi: 10.1097/PAS.0b013e31824f24a6.
7
[Renal cell carcinoma of patients younger than 40 years old].40岁以下患者的肾细胞癌
Prog Urol. 2012 Feb;22(2):93-9. doi: 10.1016/j.purol.2011.11.007. Epub 2012 Jan 4.
8
CT and MRI appearances and radiologic staging of pediatric renal cell carcinoma.小儿肾细胞癌的 CT 和 MRI 表现与放射学分期。
Pediatr Radiol. 2012 Apr;42(4):410-7; quiz 513-4. doi: 10.1007/s00247-011-2319-5. Epub 2012 Jan 17.
9
Molecular heterogeneity of TFE3 activation in renal cell carcinomas.TFE3 激活在肾细胞癌中的分子异质性。
Mod Pathol. 2012 Feb;25(2):308-15. doi: 10.1038/modpathol.2011.169. Epub 2011 Oct 28.
10
Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.伴药物反应的舒尼替尼相关性肾病综合征一例:Xp11.2 易位肾细胞癌。
Jpn J Clin Oncol. 2011 Nov;41(11):1277-81. doi: 10.1093/jjco/hyr140. Epub 2011 Sep 29.